Confocal analysis confirmed that CCL21-expressing FRCs were significantly reduced in both murine and human DLBCL tumors (Figure 6A and Supplemental Figure 6A) and showed decreased CCL19 expression (Supplemental Figure 6B). The gene discussed is CCL19; the disease is diffuse large B-cell lymphoma.